Slides
Page 1
Q2 2026 RESULTS Earnings Call NASDAQ GLOBAL MARKET : CCLD A leading provider of technology - enabled services and Al - based solutions for the healthcare revenue cycle © CareCloud , Inc. 2026 CareCloud
Page 2
Q 2 2 0 2 6 E A R N I N G S C A L L 00 F O R W A R D- L O O K I N G S T A T E M E N T S Safe Harbor Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify f orward- looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target, ” “approximately,” or “continue” or the negative of these terms or other similar terms and phrases. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward -looking statements ultimately prove to be correct. Forward-looking statements in this presentation include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, including our ability to continue as a going concer n, to raise additional capital and to succeed in our future operations, profitability and business outlook, increased sales and mar keting expenses, and the expected results from the integration of our acquisitions. MATERIAL RISK FACTORS — OUR ABILITY TO: • Maintain operations in Pakistan, Azad Jammu and Kashmir, and Sri Lanka in a manner that continues to enable us to offer competitively priced products and services; • Operate in a global business environment that may be affected by geopolitical developments, including regional conflicts, trade restrictions, sanctions, changes in diplomatic relations or political stability; • Consistently achieve and maintain compliance with a myriad of federal, state, foreign, local, payor and industry requirements, regulations, rules, laws and contracts; • Respond to the recent cybersecurity incident and effectively integrate, manage and keep our information systems secure and operational in the event of another cyber-attack; • Manage our growth, including acquiring, partnering with, and effectively integrating the acquisitions of Empower Healthcare & Compliance Partners, MAP App, Medsphere Systems Corporation, RevNu Medical Management and other acquired businesses into our infrastructure and avoiding legal exposure and liabilities associated with our acquisitions; • Retain our clients and revenue levels, including effectively migrating new clients and maintaining or growing the revenue levels of our new and existing clients; • Keep pace with a rapidly changing healthcare industry, including the use of artificial intelligence (“AI”); • Maintain and protect the privacy of confidential and protected Company, client and patient information; • Develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards and third-party software platforms and technologies, and protect and enforce all of these and other intellectual property rights; • Attract and retain key officers and employees, and the continued involvement of Mahmud Haq as Executive Chairman, Stephen Snyder as Chief Executive Officer and A. Hadi Chaudhry as Chief Strategy Officer, all of which are critical to our ongoing operations and growing our business; • Realize the expected cost savings and benefits from our restructuring activities and structural cost reductions; • Make assumptions regarding the continuation, signing, scope and timing of certain client, vendor and partner relationships an d the commencement and timing of client projects, which reflect management’s current beliefs and expectations and may not materialize on the anticipated schedule or at all; • Timely and effectively complete the integration of acquired businesses and execute expense -structure and related operational initiatives necessary to align our cost structure with our adjusted EBITDA and earnings-per-share objectives; • Comply with the covenants and the required principal and interest payments contained in our credit agreement with our senior secured lenders, Citizens Bank, N.A. and Provident Bank, and other future debt facilities; • Continue to pay our monthly dividends to the holders of our Series A Preferred Stock; • Incorporate AI into our products faster and more successfully than our competitors, protecting the privacy of medical records and cybersecurity threats; • Compete with other companies developing products and selling services competitive with ours, and who may have greater resourc es and name recognition than we have; • Respond to the uncertainty resulting from pandemics, epidemics or other public health emergencies and the impact they may hav e on our operations, the demand for our services, our projected results of operations, financial performance or other financial me trics or any of the foregoing risks and economic activity in general; • Keep and increase market acceptance of our products and services; • Respond to changes in domestic and foreign business, market, financial, political and legal conditions; and • Other factors disclosed in this Quarterly Report on Form 10-Q or our other filings with the Securities and Exchange Commission (the “SEC”). Although we believe that the expectations reflected in the forward-looking statements contained in this presentation are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. In this presentation, we disclose certain non-GAAP historical and projected financial measures, including adjusted EBITDA. We be lieve that these non-GAAP financial measures provide useful information to both management and investors by excluding certain items and expenses that are not indicative of our core operating results or do not reflect our normal business operations. Ou r use of non-GAAP financial measures has certain limitations in that such non-GAAP financial measures may not be directly comparable to those reported by other companies. We seek to compensate for the limitation of our non -GAAP financial measures by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable U.S. GAAP financial measures. Investors are encouraged to review the related U.S. GAAP financial measures and the reconciliation of these non -GAAP financial measures to their most directly comparable U.S. GAAP financial measures. The statements in this presentation are made as of the date of this presentation, and the Company does not assume any obligat ions to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made. C A R E C L O U D , I N C . N A S D A Q : C C L D 01
Page 3
Q 2 2 0 2 6 E A R N I N G S C A L L 01 H O S T S F O R Q 2 2 0 2 6 E A R N I N G S C A L L Today's Speakers Mahmud Haq FOUNDER & EXECUTIVE CHAIRMAN Stephen Snyder CHIEF EXECUTIVE OFFICER Hadi Chaudhry CHIEF STRATEGY OFFICER Norman Roth CFO & CORPORATE CONTROLLER C A R E C L O U D , I N C . 02
Page 4
02 O P E N I N G R E M A R K S · Q 2 2 0 2 6 Stephen Snyder — CHIEF EXECUTIVE OFFICER C A R E C L O U D , I N C . 03
Page 5
Q 2 2 0 2 6 E A R N I N G S C A L L 03 Q 2 2 0 2 6 F I N A N C I A L H I G H L I G H T S Key metrics at a glance Revenue up 16% year-over-year, led by technology-enabled solutions. Profitability reflects continued AI investment, integration costs, and higher acquisition-related amortization. R E V E N U E $31.9M +16% year-over-year G A A P N E T I N C O M E $1.1M vs $2.9M in Q2'25 A D J . N E T I N C O M E ¹ $2.4M vs $3.3M in Q2'25 A D J U S T E D E B I T D A ¹ $5.9M 19% of revenue F R E E C A S H F L O W ¹ $5.7M vs $5.4M in Q2'25 G A A P E P S $0.00 vs $0.04 in Q2'25 C A R E C L O U D , I N C . (1) NON -GAAP MEASURE — SEE APPENDIX 04
Page 6
Q 2 2 0 2 6 E A R N I N G S C A L L 0 4 E m p o w e r A c q u i s i t o n Empower adds compliance to the CareCloud platform In May, CareCloud acquired Empower Healthcare & Compliance Partners, a full-service healthcare compliance and advisory firm, in an asset purchase funded from operating cash flow. Empower brings audit defense, revenue integrity, privacy & security, and compliance & ethics services — a natural cross-sell across the 45,000+ providers already on our platform. D E A L C L O S E D / M A Y 1 5 , 2 0 2 6 Empower is now a CareCloud company Founder Mitchell Brie joins as President of Empower, continuing CareCloud's track record of 20+ tuck-in acquisitions since IPO, typically integrated within a few quarters. E A R L Y W I N / J U N E 2 0 2 6 $1M+ in alleged overpayments reversed for a client Within weeks of closing, Empower's certified coding and audit-defense expertise helped a wound-care provider reverse more than $1 million in alleged overpayments before the Office of Medicare Hearings and Appeals. N E T I M P A C T Opens a new, recurring revenue stream in high-demand compliance services - funded from cash flow, cross-sold into 40,000+ providers, with AI-powered compliance SaaS launching in H2 2026. C A R E C L O U D , I N C . 05
Page 7
Q 2 2 0 2 6 E A R N I N G S C A L L 0 5 B U S I N E S S U P D A T E · C A P I T A L S T R U C T U R E Series B redemption strengthens capital structure Replaced 8.75% Series B preferred equity with institutional bank financing — simplifying the capital structure and increasing flexibility to fund future growth. S E R I E S B R E D E E M E D 100% All 1,511,372 shares redeemed May 15, 2026 at $27.52 per share, including accumulated and unpaid dividends; subsequently delisted from Nasdaq. R E D E M P T I O N F U N D I N G $41.6M Funded through the new $50M Citizens Bank & Provident Bank credit facility — $40M term loan and $10M revolving line. A N N U A L S E R I E S B D I V I D E N D O B L I G A T I O N E L I M I N A T E D ~$3.3M Recurring Series B preferred dividend obligation removed and accumulated arrears resolved. C O M M O N- S T O C K A T M A V A I L A B L E $60M Opportunistic growth capital only — management intends to access it only at or above $5.00 per share; no shares sold to date. S T R A T E G I C I M P A C T Replaces higher-cost preferred equity with lower-cost institutional financing Eliminates the recurring Series B dividend burden and resolves the arrearage Simplifies the capital structure and improves capital-allocation flexibility Preserves capacity to fund acquisitions and organic growth opportunities N E T I M P A C T A major step in CareCloud's capital structure evolution — removing the Series B dividend burden while preserving disciplined access to capital for future growth. C A R E C L O U D , I N C . 06
Page 8
Q 2 2 0 2 6 E A R N I N G S C A L L 0 6 F Y 2 0 2 6 G U I D A N C E FY 2026 guidance reaffirmed Revenue $M $111 FY24 $120 FY25 $128–132 FY26E Adjusted EBITDA* $M $24 FY24 $28 FY25 $29–31 FY26E GAAP EPS $ per share FY24 $(0.28) $0.10 FY25 $0.20–0.23 FY26E C A R E C L O U D , I N C . * NON -GAAP MEASURE — SEE APPENDIX 07
Page 9
0 7 A I & S T R A T E G Y · Q 2 2 0 2 6 Hadi Chaudhry — CHIEF STRATEGY OFFICER C A R E C L O U D , I N C . 08
Page 10
Q 2 2 0 2 6 · O U R A I S T R A T E G Y Three Tracks. Progress on All Three. 01 Back-end Optimization AI doing our existing RCM, financial, and administrative work — faster, more accurate, at lower cost. ✓ Q2: higher volumes, same headcount 02 Embedded AI in Existing Apps AI inside the products clients already use — making them smarter, stickier, more valuable. ✓ Q2: AI live in Wellsoft & Marketware 03 New AI Products stratusAI, cirrusAI, and an expanding pipeline — new revenue lines from standalone AI. ✓ Q2: pilots underway, launches on track The substance behind the strategy — a quarter of visible, measurable progress on every track. 09 Q 2 2 0 2 6 E A R N I N G S C A L L C A R E C L O U D , I N C . 08
Page 11
TRACK 3 / THE PIPELINE What's Coming Next In active development inside the AI Center of Excellence — on track to bring to market this year. F R O M T H E A I C E N T E R O F E X C E L L E N C E T O M A R K E T · 2 0 2 6 I N P I L O T D E P L O Y M E N T S AI Prior Authorization Cuts revenue leakage & turnaround time Predicts requirements, pre-populates documentation, routes requests automatically — now in live pilots. I N D E V E L O P M E N T AI-Assisted Medical Coding Higher first-pass acceptance, fewer denials AI-suggested codes confirmed by human coders — already proving out inside our own RCM operations. I N D E V E L O P M E N T Additional Clinical Documentation Provider time saved, better records Ambient documentation beyond Notes — expanding to new workflows and specialties. 10 Q2 2026 EARNINGS CALL CARECLOUD, INC. 09
Page 12
TRACK 3 / stratusAI FRONT DESK Strong Demand. Disciplined Deployment. THE DEMAND What the market is telling us • New business signed through Q2 • Demand from across the client base • Product performing in production THE DISCIPLINE Depth before breadth Every signed agent implemented well — trial to expansion Implementation quality prioritized over deployment count Expansion = more agents, more functions, longer hours, broader use cases Each deployment hardens the operational playbook THE PATH TO REVENUE Durable, Recurring Revenue Revenue is early — the operational foundation being built now is what converts these deployments into durable, recurring revenue. We will report it as it scales. 11 Q2 2026 EARNINGS CALL CARECLOUD, INC. 10
Page 13
PLATFORM EXECUTION / COMMITTED LAST QUARTER We Said. We Did. Specific, dated commitments made last quarter — reported against directly. D E L I V E R E D I N Q 2 W H A T I T M E A N S ✓ Legacy parity closed — ambulatory revenue cycle R C M C L O U D Same platform, fully current — clients gain modern capabilities with zero migration. ✓ Q2 parity items completed — inpatient EHR C A R E V U E A better, modern platform — full parity delivered in place; no disruption for hospital clients. ✓ Digital patient experience live in the ED B R E E Z E × W E L L S O F T Digital-first emergency care — patients check in, communicate, and engage digitally. ✓ Ambient AI clinical notes live in the ED C I R R U S A I N O T E S × W E L L S O F T AI drafts, physicians review — ambient documentation at the point of care. NEXT stratusAI front desk in the ED — Q3 · Wellsoft as full cloud SaaS — this year 12 Q2 2026 EARNINGS CALL CARECLOUD, INC. 11
Page 14
TRACK 2 / MARKETWARE Marketware: Now an AI-Powered Recruitment Engine PracticeMatch Flagship integration — live DocCafe Integration — live Candidate Portal Apply & submit credentials online AI Matching Candidate recommendations — live + 20+ enhancements delivered in Q2 THE SHIFT From CRM to Recruiting Engine Physicians and hospital staff apply and submit credentials directly to hiring managers — with AI matching candidates to roles. COMING IN Q3 WorkDay & DocuSign Another 20+ enhancements underway for Q3 — led by WorkDay and DocuSign integrations. 13 Q2 2026 EARNINGS CALL CARECLOUD, INC. 12
Page 15
WHERE THIS IS HEADING One Unified Platform Today Growth through acquisition left us running independent platforms — each with its own back end. The Move Consolidating onto a single, modular platform — clients turn on the modules they need. The Discipline A multi-year journey, sequenced deliberately — no dates today; the direction is set. THE DESTINATION One Foundation, Every Module One back end — shared data, one patient record across care settings Modular by design — ambulatory, inpatient, RCM, compliance, patient engagement Common data & AI foundation — every new AI capability deploys everywhere at once Fewer, stronger platforms — one place to bring our AI to bear, one surface to secure. 14 Q2 2026 EARNINGS CALL CARECLOUD, INC. 13
Page 16
14 F I N A N C I A L R E V I E W · Q 2 2 0 2 6 Norman Roth — CFO & CORPORATE CONTROLLER C A R E C L O U D , I N C . 15
Page 17
Q 2 2 0 2 6 E A R N I N G S C A L L 15 F I N A N C I A L R E V I E W Q2 2026 highlights Revenue $M $27.4 Q2'25 $31.9 Q2'26 Net Income $M $2.9 Q2'25 $1.1 Q2'26 C A R E C L O U D , I N C . 16 Adjusted EBITDA* $M $6.5 Q2'25 $5.9 Q2'26 Free Cash Flow* $M $5.4 Q2'25 $5.7 Q2'26 Adjusted Net Income* $M $3.3 Q2'25 $2.4 Q2'26 * NON -GAAP MEASURE — SEE APPENDIX
Page 18
Q 2 2 0 2 6 E A R N I N G S C A L L 16 F I N A N C I A L R E V I E W YTD 2026 highlights C A R E C L O U D , I N C . 17 Net Income $M $4.9 YTD'25 $2.0 YTD'26 Revenue $M $55.0 YTD'25 $63.2 YTD'26 Revenue $M Adjusted EBITDA* $M $12.1 YTD'25 $11.3 YTD'26 Free Cash Flow* $M $9.1 YTD'25 $8.1 YTD'26 Adjusted Net Income* $M $5.6 YTD'25 $4.5 YTD'26 * NON -GAAP MEASURE — SEE APPENDIX
Page 19
17 C L O S I N G R E M A R K S · Q 2 2 0 2 6 Mahmud Haq — FOUNDER & EXECUTIVE CHAIRMAN C A R E C L O U D , I N C . 18
Page 20
Thank You! I N V E S T O R R E L A T I O N S ir.carecloud.com C O N T A C T ir@carecloud.com W E B carecloud.com C A R E C L O U D , I N C . 19
Page 21
N O N - G A A P R E C O N C I L I A T I O N S Appendix C A R E C L O U D , I N C . 20
Page 22
Q 2 2 0 2 6 E A R N I N G S C A L L A1 N O N- G A A P R E C O N C I L I A T I O N GAAP Net Income to Adjusted EBITDA $ I N T H O U SA N D S Q2'25 Q2'26 GAAP net income $ 2,902 $ 1,122 Provision for income taxes 42 102 Net interest expense 17 742 Foreign exchange / other expense 41 54 Stock-based compensation expense 111 64 Depreciation and amortization 3,382 3,731 Transaction and integration costs 11 166 Restructuring costs 23 — Change in contingent consideration — (34) Adjusted EBITDA $ 6,529 $ 5,947 C A R E C L O U D , I N C . APPENDIX 21 YTD'25 YTD'26 $ 4,850 $ 2,044 83 154 33 790 60 86 219 128 6,719 7,768 23 324 137 — — 23 $ 12,124 $ 11,317
Page 23
Q 2 2 0 2 6 E A R N I N G S C A L L A2 N O N- G A A P R E C O N C I L I A T I O N GAAP Net Income to Adjusted Net Income $ I N T H O U S A N D S Q2'25 Q2'26 GAAP net income $ 2,902 $ 1,122 Foreign exchange / other expense 41 54 Stock-based compensation expense 111 64 Amortization of purchased intangible assets 193 945 Transaction and integration costs 11 166 Restructuring costs 23 — Change in contingent consideration — (34) Income tax expense related to goodwill — 50 Adjusted Net Income $ 3,281 $ 2,367 C A R E C L O U D , I N C . APPENDIX 22 YTD'25 YTD'26 $ 4,850 $ 2,044 60 86 219 128 282 1,873 23 324 137 — — 23 — 50 $ 5,571 $ 4,528
Page 24
Q 2 2 0 2 6 E A R N I N G S C A L L A3 N O N- G A A P R E C O N C I L I A T I O N Net Cash Provided by Operating Activities to Free Cash Flow $ I N T H O U S A N D S Q2'25 Q2'26 Net cash provided by operating activities $ 7,408 $ 7,073 Purchases of property and equipment ( 1,162 ) (525) Capitalized software & other intangible assets ( 831 ) (800) Free Cash Flow $ 5,415 $ 5,748 Net cash used in investing activities ¹ $ ( 1,993 ) $ (2,006) Net cash (used in) provided by financing activities $ ( 1,762 ) $ 4,474 1. Net cash used in investing activities includes payments for acquisitions, purchases of property and equipment and capitalized software and other intangible assets. Purchases of property and equipment and capitalized software and other intangible assets are included in our computation of free cash flow. C A R E C L O U D , I N C . APPENDIX 23 YTD'25 YTD'26 $ 12,521 $ 10,684 ( 1,786 ) ( 937 ) ( 1,677 ) ( 1,620 ) $ 9,058 $ 8,127 $ ( 3,503 ) $ ( 3,238 ) $ ( 3,694 ) $ 2,324